Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral Therapy
Clinical trial NCT01258686 · COMPLETED
Trial details
- NCT number
- NCT01258686
- Sponsor
- Bukwang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2012-11-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.